1 of 1
Story summary
- The U.S. Supreme Court temporarily restored nationwide mail access to mifepristone after a federal appeals court limited it.
- Anti-abortion groups called it a five-alarm crisis and urged FDA commissioner Dr. Marty Makary to speed safety review.
- Abortion-rights and anti-abortion advocates are mobilizing voters for the 2026 midterms as pill rulings intensify.
- President Donald Trump has withheld Planned Parenthood funds while avoiding the issue, prompting pro-life groups to pressure his administration.
